ArticlePloS one2014

Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.

Nicholas J Izzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.